Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020199860 - BINDER AGAINST PROGRAMMED DEATH-LIGAND AND APPLICATION THEREOF

Publication Number WO/2020/199860
Publication Date 08.10.2020
International Application No. PCT/CN2020/078596
International Filing Date 10.03.2020
IPC
C07K 16/28 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
28against receptors, cell surface antigens or cell surface determinants
C07K 19/00 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
19Hybrid peptides
G01N 33/68 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
G01N 33/577 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
577involving monoclonal antibodies
G01N 33/574 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
574for cancer
A61K 39/395 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Applicants
  • 华博生物医药技术(上海)有限公司 HUABO BIOPHARM (SHANGHAI) CO., LTD. [CN]/[CN]
Inventors
  • 于海佳 YU, Haijia
  • 俞玲 YU, Ling
  • 蔡明清 CAI, Mingqing
  • 朱向阳 ZHU, Xiangyang
Agents
  • 上海一平知识产权代理有限公司 XU & PARTNERS, LLC.
Priority Data
201910258182.501.04.2019CN
Publication Language Chinese (ZH)
Filing Language Chinese (ZH)
Designated States
Title
(EN) BINDER AGAINST PROGRAMMED DEATH-LIGAND AND APPLICATION THEREOF
(FR) LIANT CONTRE LE LIGAND DE MORT PROGRAMMÉE ET SON APPLICATION
(ZH) 针对程序性死亡配体的结合物及其应用
Abstract
(EN)
Provided is an anti-PD-L1 monoclonal antibody. The antibody can be used to prepare a drug for preventing or treating a disease related to PD-L1.
(FR)
L'invention concerne un anticorps monoclonal anti-PD-L1. L'anticorps peut être utilisé pour préparer un médicament pour prévenir ou traiter une maladie liée à PD-L1.
(ZH)
提供了一种抗PD-L1单克隆抗体,可用于制备预防或治疗PD-L1相关的疾病的药物。
Latest bibliographic data on file with the International Bureau